According to the company, the new release supports several languages and includes performance and usability enhancements, such as mobile download access from the Apple App Store and Google Play Store.
Kyle Devin Hogan, eClinical Solutions Director told us that the primary focus of the new release surrounds increasing patient adherence and giving more visibility to sponsors.
“In addition to delivering patient engagement capabilities, we also offer ePRO through our app,” said Hogan.
The new release is part of Clinical Ink's SureSource platform.
“I think going down the road we'll continue to enhance the engaging capabilities to directly drive that adherence mission,” added Hogan.
"We really want to see the application aid sponsors in improving patients showing up to visits when they need to, completing questionnaires, and taking the medication when they’re supposed to.”